Literature DB >> 12147269

Role of prostaglandin E(2) EP receptors and cAMP in the expression of connective tissue growth factor.

Jun Yu1, Gregory N Prado, Barbara Schreiber, Paul Polgar, Peter Polgar, Linda Taylor.   

Abstract

Wild-type (WT) Rat-1 fibroblasts express undetectable quantities of the prostaglandin E(2) (PGE(2)) EP1, EP2, and EP3 receptor types and detectable amounts of the EP4 receptor. In the WT Rat-1, PGE(2) enhances connective tissue growth factor (CTGF) mRNA. PGE(2) does not stimulate cAMP production in these cells. However, forskolin induces cAMP production and ablates TGF beta-stimulated increases in CTGF mRNA. A similar pattern of CTGF expression in response to PGE(2) and forskolin is observed in neonatal rat primary smooth muscle cell cultures. When WT Rat-1 cells are stably transfected with the EP2 receptor, PGE(2) causes a sizable elevation in intracellular cAMP and ablates the TGF beta-stimulated increase in CTGF mRNA. PGE(2) does not have this effect on cells expressing the EP1, EP3, or EP4 receptor subtypes. These results demonstrate the importance of the EP2 receptor and cAMP in the inhibition of TGF beta-stimulated CTGF production and suggest a role for PGE(2) in increasing CTGF mRNA levels in the absence of the EP2 receptor. Involvement of inositol phosphate in this upregulation of CTGF expression by PGE(2) is doubtful. None of the cell lines containing the four EP transfectants nor the WT Rat-1 cells responded to PGE(2) with inositol phosphate production. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147269     DOI: 10.1016/s0003-9861(02)00276-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Prostaglandin E2 regulates the expression of connective tissue growth factor (CTGF/CCN2) in human osteoarthritic chondrocytes via the EP4 receptor.

Authors:  Kayo Masuko; Minako Murata; Kazuo Yudoh; Hiroyuki Shimizu; Moroe Beppu; Hiroshi Nakamura; Tomohiro Kato
Journal:  BMC Res Notes       Date:  2010-01-15

2.  Connective tissue growth factor is required for normal follicle development and ovulation.

Authors:  Takashi Nagashima; Jaeyeon Kim; Qinglei Li; John P Lydon; Francesco J DeMayo; Karen M Lyons; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-08-25

3.  Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production.

Authors:  Rebecca J Hodges; R Gisli Jenkins; Caroline P D Wheeler-Jones; Danielle M Copeman; Stephen E Bottoms; Geoffrey J Bellingan; Carmel B Nanthakumar; Geoffrey J Laurent; Stephen L Hart; Martyn L Foster; Robin J McAnulty
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 4.  cAMP and Epac in the regulation of tissue fibrosis.

Authors:  Paul A Insel; Fiona Murray; Utako Yokoyama; Silvia Romano; Hongruo Yun; Loren Brown; Aaron Snead; David Lu; Nakon Aroonsakool
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

5.  Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms.

Authors:  A Hari Kishore; David Owens; R Ann Word
Journal:  J Clin Endocrinol Metab       Date:  2014-01-28       Impact factor: 5.958

6.  Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase.

Authors:  Samuel A Black; Amitha H Palamakumbura; Maria Stan; Philip C Trackman
Journal:  J Biol Chem       Date:  2007-04-10       Impact factor: 5.157

7.  The presence and regulation of connective tissue growth factor in the human endometrium.

Authors:  J A Maybin; J Barcroft; U Thiruchelvam; N Hirani; H N Jabbour; H O D Critchley
Journal:  Hum Reprod       Date:  2012-02-09       Impact factor: 6.918

8.  Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo.

Authors:  David R Brigstock
Journal:  J Cell Commun Signal       Date:  2009-03-18       Impact factor: 5.782

9.  The roles of connective tissue growth factor in the development of anastomotic esophageal strictures.

Authors:  Haibin Zhao; Lingna Zhao; Zhihua Zhou; Yaoyi Wu
Journal:  Arch Med Sci       Date:  2015-01-08       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.